The company’s proprietary technology platform is based on dendritic cells mediating antigen-specific tolerance for the prevention or cure of diseases where the immune system is the enemy.
Cell4Cure
Cell4Cure AB is a Swedish, privately held cell therapy company committed to the development of treatments for the induction of immune tolerance.
